Last reviewed · How we verify

NCT06777667: FSRRFD

Fibromyalgia Severity: Role of Resilience and Family Dynamics

Completed Last updated 30 April 2025
What this trial tests

trial in Fibromyalgia in 194 participants. Completed in 1 March 2025.

Timeline
28 November 2024
Primary endpoint
1 March 2025
1 March 2025

Quick facts

Lead sponsorAntalya Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment194
Start date28 November 2024
Primary completion1 March 2025
Estimated completion1 March 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Antalya Training and Research Hospital

Who can join

Adults 25 to 45, female only, with Fibromyalgia or Resilience. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This cross-sectional survey study aims to examine the resilience and family dynamics between newly diagnosed fibromyalgia (FM) patients and healthy individuals. The study will analyze demographic data including parental attitude and childhood trauma and resilience levels using the Connor-Davidson Resilience Scale (CD-RISC-10) in fibromyalgia patients and healthy controls. The Revised Fibromyalgia Impact Questionnaire (FIQR) will also be administered to FM patients to determine the total impact and severity of the disease (mild, moderate, severe, very severe). In addition to aiming to reveal how FM patients compare to healthy individuals in terms of resilience and parental attitude, this study will also examine the relationship between disease severity and these psychosocial variables. As a result, the data obtained are expected to reveal both potential differences in resilience and family problems in FM patients and the relationship of these factors with disease severity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Antalya Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06777667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing